GINKGO BIOWORKS HOLDINGS, INC. (DNA) Operating cash flow 2019–2025
GINKGO BIOWORKS HOLDINGS, INC. (DNA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$171.1MFY2025 · since FY2019: -$44.7M → -$171.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$171.1M | +46.5% |
| FY2024 | -$319.6M | -8.2% |
| FY2023 | -$295.5M | -17.2% |
| FY2022 | -$252.2M | +0.6% |
| FY2021 | -$253.8M | -86.9% |
| FY2020 | -$135.8M | -204.1% |
| FY2019 | -$44.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice